VTVT
vTv TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The supported bull case is narrow but real: cadisegliatin remains a late-stage asset with Breakthrough Therapy designation, CATT1 enrollment is guided for 3Q 2026, and company filings indicate financing plus the Newsoara payment should fund operations well past the expected topline window [#10-K-2026-03-10].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -5.9.
What can break
CATT1 enrollment or follow-up could slip, delaying the main value inflection beyond management's 3Q 2026 enrollment expectation [#10-K-2026-03-10].
Momentum
83
Value
41
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $31.00 · Bull $48.00 · Bear $18.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $55.25
Why
Momentum83 · Δ7d -5.9
Value41 · Δ7d +0.1
Sentiment46 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
83
34% active weight
Current posture
7d trendSoftening
Δ7d
-5.9
Δ21d
-
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
46
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 82.9 / Value 41.1 / Sentiment 45.7
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$135.1M
Beta
0.50
Shares Out
3.94M
P/E (TTM) · Derived
-10.7
P/S (TTM)
9817.85
P/FCF (TTM) · Derived
-11.45
Rev YoY
-100.0%
EPS YoY
-23.2%
Gross Margin
-
Op Margin
-175382.4%
Net Debt
-$36.75M
Current Ratio
9.79
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology